GLP-1 analogues may decrease the formation of amyloid plaques, mitigate memory impairment, prevent synapse loss in the hippocampus, and restore synaptic plasticity in a mouse model of Alzheimer's disease (AD) [28,29]. This evidence concerns the gene GLP1R and early-onset autosomal dominant Alzheimer disease.